Pendekatan Modern Dalam Manajemen Luka Bakar : Tinjauan Literatur Tentang Balutan Inovatif Dan Terapi Adjuvan
DOI:
https://doi.org/10.63822/05633s65Keywords:
Burns; Hydrogel; Silver sulfadiazine; Silver nanoparticles; Adjuvant therapyAbstract
Burns are a condition that can cause high morbidity due to tissue damage, a high risk of infection, fluid loss, and obstacles to the healing process. Various modern treatment strategies continue to be developed to improve clinical outcomes and minimize complications. Objective: This review aims to evaluate the effectiveness of various innovative dressings and current adjuvant therapies—including hydrogel, next-generation silver sulfadiazine, silver nanoparticles, and alginate–zeolite biomaterials—in accelerating burn wound healing. Methods: The method used is a literature review method by searching articles using the PubMed, Google Scholar, and ScienceDirect databases with keywords burn injury, hydrogel dressing, silver sulfadiazine, silver nanoparticles, alginate hydrogel, and adjuvant therapy, limited to publications from 2020-2025 and filtered based on certain inclusion criteria. A total of eight selected articles were then analyzed thematically. Results: The results indicate that modern dressings and adjuvant therapies provide superior clinical outcomes compared to conventional methods, including accelerated re-epithelialization, reduced infection, and improved new tissue quality. Conclusion: Overall, the use of biomaterials and nanomedicine technology can be considered more effective in supporting burn wound healing and is worthy of consideration as a recommendation in clinical practice
References
Badreldin, Y. A., & Al-mekhlafi, G. A. (2024). Hydrogel-Based Dressings and Multidisciplinary Care in Severe Pediatric Burns : A Case Report of Successful Healing and Hypertrophic Scar Prevention. 1–7. https://doi.org/10.12659/AJCR.944021
Hassan, S., Ahmadabadi, A., Yazarlou, O., Safari, H., Kouhi, M., Emadi, E., & Hamidi, D. (2025). Burns Open A novel non-invasive treatment in deep burned patients who do not have consent to surgery. Burns Open, 10(November 2024), 100392. https://doi.org/10.1016/j.burnso.2024.100392
Kubavat, J., Sarvaiya, J., Tyagi, T., Banerjee, S., & Aggarwal, P. (2023). Burns Open Development of Levan capped silver nanoparticles based product and its effect on wound healing. Burns Open, 7(1), 8–21. https://doi.org/10.1016/j.burnso.2022.12.002
Moghadam, S. S., Momeni, M., & Atabaki, S. M. (2022). Topical Treatment of Second-Degree Burn Wounds with Lactobacillus plantarum Supernatant : Phase I Trial. 17(4), 460–468.
Priyadarsini, S. L., Suresh, M., & Nikhila, G. (2023). Heliyon Assessment framework for the selection of a potential interactive dressing material for diabetic foot ulcer. Heliyon, 9(6), e16476. https://doi.org/10.1016/j.heliyon.2023.e16476
Samadian, H., Vahidi, R., Salehi, M., Hosseini-nave, H., Shahabi, A., Lashkari, M., Kouhbananinejad, S. M., & Rezaei, N. (2022). Hydrogel nanocomposite based on alginate / zeolite for burn wound healing : In vitro and in vivo study.
Schulman, C. I., Aickara, D., Rodriguez-menocal, L., Namias, N., Pizano, L., Guzman, W., Candanedo, A., & Badiavas, E. V. (2025). Therapeutic role of mesenchymal stem cells in second-degree burn wound repair : Integration with split-thickness skin grafts. 11, 1–7. https://doi.org/10.1177/20595131251357442
Schulman, C. I., Namias, N., Pizano, L., Rodriguez-menocal, L., Aickara, D., Guzman, W., Mcbride, D., & Badiavas, E. V. (2022). The e ff ect of mesenchymal stem cells improves the healing of burn wounds : a phase 1 dose-escalation clinical trial. 1–15. https://doi.org/10.1177/20595131211070783
Yamamoto, Y., Fujihara, H., Kirita, M., & Soejima, K. (2022). Burns Open Micronized dermal grafts ( Rigenera TM ) and split-thickness skin grafts alone or in combination for deep dermal burn wounds. 6(July), 212–217.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Dearahayu, Chindy Nur Fadilla, Dea, Anggi Suciyana Safitri, Anyu Tasyaning, Islaeli Islaeli (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
